ME-3183

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameME-3183
Drug Alias NameME-3183
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitorsPhosphodieterase 4 inhibitors
TargetsTumor necrosis factor αPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika Pharmatech Co LtdMeiji Pharma USA Inc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A